1
|
AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.
|
Acta Physiol (Oxf)
|
2009
|
2.13
|
2
|
A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts.
|
Diabetologia
|
2012
|
1.83
|
3
|
CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide.
|
Clin Exp Allergy
|
2014
|
1.56
|
4
|
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status.
|
Diabetologia
|
2011
|
1.48
|
5
|
Mitochondrial metabolism and type-2 diabetes: a specific target of metformin.
|
Diabetes Metab
|
2003
|
1.26
|
6
|
The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells.
|
Biochem Pharmacol
|
2010
|
1.00
|
7
|
Glucose 6-phosphate hydrolysis is activated by glucagon in a low temperature-sensitive manner.
|
J Biol Chem
|
2001
|
0.81
|
8
|
Lack of starvation-induced activation of AMP-activated protein kinase in the hypothalamus of the Lou/C rats resistant to obesity.
|
Int J Obes (Lond)
|
2007
|
0.80
|
9
|
Liver mitochondrial properties from the obesity-resistant Lou/C rat.
|
Int J Obes (Lond)
|
2008
|
0.76
|
10
|
Metabolic and hormonal responses to exercise in the anti-obese Lou/C rats.
|
Int J Obes Relat Metab Disord
|
2004
|
0.76
|
11
|
The insulin sensitizing effect of topiramate involves KATP channel activation in the central nervous system.
|
Br J Pharmacol
|
2013
|
0.75
|